HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials

Fred M. Kusumoto, Hugh Calkins, John Boehmer, Alfred E. Buxton, Mina K. Chung, Michael R. Gold, Stefan H. Hohnloser, Julia Indik, Richard Lee, Mandeep R. Mehra, Venu Menon, Richard L. Page, Win Kuang Shen, David J. Slotwiner, Lynne Warner Stevenson, Paul D. Varosy, Lisa Welikovitch

Research output: Contribution to journalArticle

57 Scopus citations
Original languageEnglish (US)
Pages (from-to)94-125
Number of pages32
JournalCirculation
Volume130
Issue number1
DOIs
StatePublished - Jul 1 2014

Keywords

  • AHA Scientific Statements
  • Heart failure
  • Implantable cardioverter- defibrillator therapy
  • Sudden cardiac death

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

Kusumoto, F. M., Calkins, H., Boehmer, J., Buxton, A. E., Chung, M. K., Gold, M. R., Hohnloser, S. H., Indik, J., Lee, R., Mehra, M. R., Menon, V., Page, R. L., Shen, W. K., Slotwiner, D. J., Stevenson, L. W., Varosy, P. D., & Welikovitch, L. (2014). HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials. Circulation, 130(1), 94-125. https://doi.org/10.1161/CIR.0000000000000056